🇺🇸 FDA
Patent

US 11667900

Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication

granted A61KA61K38/00A61K39/39558

Quick answer

US patent 11667900 (Compositions and methods for enhancing macrophage-mediated antibody guided cancer cell or tumor eradication) held by The Regents of the University of California expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00, A61K39/39558